Pharmacy and drugs - search results: cipro


	About us	News	A-Z Drugs	Stores	Top Drugs	Contact

Diseases

.: Addiction
.: ADHD
.: Allergies
.: Alzheimers disease
.: Angina
.: Arthritis
.: Asthma
.: Bacterial infection
.: Birth control
.: Blood disorder
.: Breast cancer
.: Cancer
.: Diabetes
.: Digestive system
.: Ear infections
.: Erectile dysfunction
.: Eye diseases
.: Fever
.: Gastro problems
.: Glaucoma
.: Heart diseases
.: Hormones
.: Infectious diseases
.: Joint pain
.: Kidney stones
.: Lung cancer
.: Lung diseases
.: Mental Health and Depression
.: Mouth diseases
.: Neurological disorder
.: Pain relief
.: Reduce cholesterol
.: Skin diseases
.: Sleep disorder
.: Std
.: Supplement
.: Urinary tract infection
.: Weight loss
.: Womens health

Newsletter

Subscribe to our newsletter:

Name:
E-mail:

Search results

Search results for: cipro
1 - 3 of 3 <<previous | next>>

Drugs results:

Cipro

Cipro, also called Ciprofloxacin, are part of a group of medicines called Fluoroquinolones, which are used to treat bacterial infections in many different parts of the body. They work by killing bacteria or preventing their growth. Be sure to tell your more...

Ciprofloxacin

Ciprofloxacin is an antibiotic in a group of drugs called fluoroquinolones that works by fighting bacteria in the body termed as bactericidal agents. It is used to treat different types of bacterial infections such as infections in the respiratory tract, more...

Diseases results:

Bacterial infection
Bladder infection

Articles results:

Meeting Highlights From The Committee For Medicinal Products For Human Use (CHMP), 22-24 January 2007

Initial marketing authorisation applicationsThe Committee for Medicinal Products for Human Use (CHMP) gave positive opinions recommending the granting of marketing authorisations for Januvia (sitagliptin) and Xelevia (sitagliptin), from Merck Sharp & Dohme. Both products are intended for the treatment of type-II diabetes mellitus in combination with either metformin or, in certain patients, a PPARg agonist (i.e.

Campaign Will Seek To Limit Physicians' Contact With Pharmaceutical Companies

The consumer advocacy group Community Catalysts and the Institute on Medicine as a Profession, a research group at Columbia University, on Tuesday plan to launch a campaign that will seek to limit the number of meals and other gifts that physicians accept from pharmaceutical companies, the

Drug Company Sales Visits Influenced Doctors, Study Finds

Almost half of sales visits by pharmaceutical company representatives advocating the use of the drug gabapentin led to doctors stating that they intended to increase their prescription of the drug or recommend it to colleagues, according to an analysis of a survey completed by the doctors shortly after the visits.

1 - 3 of 3 <<previous | next>>